INTERLEUKIN-2 Uses, Dosage, Side Effects and more
INTERLEUKIN-2 is under investigation in clinical trial NCT03475134 (TIL-ACT After NMA Chemo With IL-2 and Nivo Rescue in mMEL).
| Attribute | Details |
|---|---|
| Trade Name | INTERLEUKIN-2 |
| Generic | Human interleukin-2 |
| Human interleukin-2 Other Names | IL-2, INTERLEUKIN-2 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
